This indicates that while drug development has become more complex and expensive ... Yet, the goals of reduced costs and ...

Technologies for the rapid and efficient testing of small molecules and biologics have greatly accelerated drug discovery.

Post-Marketing Confirmatory Study DBV and FDA are in general agreement that the confirmatory study will need to demonstrate the effectiveness of the Viaskin Peanut patch and will need to be initiated ...

A medicine the pharma acquired in a $430 million buyout of Visterra in 2018 succeeded in a Phase 3 trial in IgA nephropathy, a crowded corner of drug research.

Sangamo Therapeutics shares rose after the company said the outcome of a recent successful interaction with the Food and Drug Administration provided a clear regulatory pathway to accelerated approval ...

Coriolis Pharma, a biopharma company specializing in R&D and GMP drug product development, recently announced the launch of a ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and ...

In recent years, the pharmaceutical industry has witnessed significant advancements, driven by technological innovation. One ...

The stock market witnessed a peculiar price movement involving biotech firm Bright Minds, which skyrocketed to historic ...

Analyst Colleen M. Kusy of Robert W. Baird reiterated a Buy rating on Spyre Therapeutics (SYRE – Research Report), retaining the price ...

Combined company will operate as TuHURA Biosciences, Inc. and advance pipeline of novel technologies to overcome resistance to cancer immunotherapy ...